Novel antibiotic combinations proposed for treatment of Burkholderia cepacia complex infections

Abstract

Abstract Effective strategies to manage Burkholderia cepacia complex (Bcc) infections in cystic fibrosis (CF) patients are lacking. We tested combinations of clinically available antibiotics and show that moxifloxacin-ceftazidime could inhibit 16 Bcc clinical isolates at physiologically achievable concentrations. Adding low dose of colistin improved the efficacy of the combo, especially at conditions mimicking CF respiratory secretions.

Keywords

• Burkholderia cepacia complex
• Moxifloxacin
• Ceftazidime
• Colistin
• Cystic fibrosis
• Antibiotic combinations